首页> 外国专利> Ophthalmic Pharmaceutical composition comprising 0.05 - 0.3 w / W of brivudine and a film-forming Agent selected among polyvinylpyrrolidone,Polyvinyl alcohol and polyacrylate; Preparation combined with steroidal or non steroidal drug use; and in the treatment of epithelial keratitis and herpes HSV Ocular Complications ZOster.

Ophthalmic Pharmaceutical composition comprising 0.05 - 0.3 w / W of brivudine and a film-forming Agent selected among polyvinylpyrrolidone,Polyvinyl alcohol and polyacrylate; Preparation combined with steroidal or non steroidal drug use; and in the treatment of epithelial keratitis and herpes HSV Ocular Complications ZOster.

机译:眼科药物组合物,其包含0.05-0.3%w / W的布列夫定和选自聚乙烯吡咯烷酮,聚乙烯醇和聚丙烯酸酯的成膜剂;与类固醇或非类固醇药物联合使用的制剂;以及治疗上皮性角膜炎和疱疹HSV眼部并发症ZOster。

摘要

Ophthalmic composition containing a Film Forming Agent brivudine and selected polyvinylpyrrolidone,Polyvinyl alcohol and polyacrylate; Combination preparation, and use for the treatment of HSV epithelial keratitis.Stromal keratitis and HSV ocular complications of herpes zoster ophthalmicus.
机译:包含成膜剂布列夫定和选择的聚乙烯吡咯烷酮,聚乙烯醇和聚丙烯酸酯的眼科组合物;联合制剂,用于治疗HSV上皮性角膜炎。疱疹性眼球性疱疹性角膜炎和HSV眼部并发症。

著录项

  • 公开/公告号CL2006002595A1

    专利类型

  • 公开/公告日2007-03-23

    原文格式PDF

  • 申请/专利权人 BERLIN-CHEMIE AG;

    申请/专利号CL2006002595

  • 发明设计人 WIHSMANN MARC;SCHMITZ REINHARD;

    申请日2006-09-28

  • 分类号A61K31/7064;A61K47/32;A61K9/06;A61K9/08;A61P31/22;

  • 国家 CL

  • 入库时间 2022-08-21 20:59:13

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号